LILRB1 and neoplasm: Escape mechanisms involving CD85j triggering have been reported, for instance, expression of CD85j ligands such as HLA-G on tumor cells, has been suggested to be an escape mechanism of gamma delta T-cell antitumoral activity [13] or continuous ligation of CD85j on DC can induce suppression of T cell responses[14].